{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:58:00Z","timestamp":1774328280905,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.leukres.2013.01.009","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T15:15:50Z","timestamp":1360336550000},"page":"619-623","source":"Crossref","is-referenced-by-count":22,"title":["Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas"],"prefix":"10.1016","volume":"37","author":[{"given":"Alessia","family":"Bari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Tadmor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Marcheselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana Valentina","family":"Liardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Luminari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Marmiroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Polliack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.01.009_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.23144","article-title":"The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Armitage","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2013.01.009_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","author":"Jaffe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.leukres.2013.01.009_bib0015","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma","volume":"89","author":"Project TN-HsLC","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.009_bib0020","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987\u201394.","DOI":"10.1056\/NEJM199309303291402"},{"key":"10.1016\/j.leukres.2013.01.009_bib0025","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2013.01.009_bib0030","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.01.009_bib0035","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.009_bib0040","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2013.01.009_bib0045","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.009_bib0050","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-04-0371","article-title":"CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified","volume":"10","author":"Ishida","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2013.01.009_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00432-008-0440-0","article-title":"Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U)","volume":"135","author":"Kitagawa","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.leukres.2013.01.009_bib0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-8722-4-34","article-title":"Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy","volume":"4","author":"Kim","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.leukres.2013.01.009_bib0065","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3109\/10428194.2010.508189","article-title":"Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified","volume":"51","author":"Castillo","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2013.01.009_bib0070","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.23205","article-title":"The prognostic significance of lymphopenia in peripheral T-cell and natural killer\/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project","volume":"87","author":"Mitrovic","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2013.01.009_bib0075","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3109\/10428190903318311","article-title":"Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy","volume":"50","author":"Chihara","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2013.01.009_bib0080","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2011.112","article-title":"The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma","volume":"25","author":"Wilcox","year":"2011","journal-title":"Leukemia"},{"issue":"Suppl. 4","key":"10.1016\/j.leukres.2013.01.009_bib0085","article-title":"Peripheral blood monocytosis is an independent prognostic factor for survival in diffuse large B cell lymphoma (DLBCL)","volume":"22","author":"Tadmor","year":"2011","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.leukres.2013.01.009_bib0090","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3109\/10428194.2012.690605","article-title":"Absolute monocyte\/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma","volume":"53","author":"Porrata","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2013.01.009_bib0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/10428194.2011.637211","article-title":"The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma","volume":"53","author":"Wilcox","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.leukres.2013.01.009_bib0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2011.050138","article-title":"Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in classical Hodgkin lymphoma","volume":"97","author":"Porrata","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2013.01.009_bib0105","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/pros.21202","article-title":"Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression","volume":"70","author":"Lindholm","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.leukres.2013.01.009_bib0110","first-page":"11","article-title":"Tumor-associated macrophages: effectors of angiogenesis and tumor progression","volume":"1796","author":"Coffelt","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.leukres.2013.01.009_bib0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.2011.08678.x","article-title":"Myeloid-derived suppressor cells \u2013 their role in haemato-oncological malignancies and other cancers and possible implications for therapy","volume":"153","author":"Tadmor","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.01.009_bib0120","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2010-05-283820","article-title":"Immunosuppressive CD14+HLA-DRlow\/-monocytes in B-cell non-Hodgkin lymphoma","volume":"117","author":"Lin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.009_bib0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.leukres.2013.01.009_bib0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J Roy Stat Soc Ser. B Method"},{"key":"10.1016\/j.leukres.2013.01.009_bib0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.leukres.2013.01.009_bib0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01621459.1987.10478435","article-title":"Supremum versions of the log-rank and generalized Wilcoxon statistics","volume":"82","author":"Fleming","year":"1987","journal-title":"J Am Stat Assoc"},{"issue":"s1","key":"10.1016\/j.leukres.2013.01.009_bib0145","first-page":"127","article-title":"Absolute Monocyte count is associated with adverse prognosis in diffuse large B-cell lymphoma: a validation study in a cohort of 219 patients from two centers","volume":"97","author":"Tadmor","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2013.01.009_bib0150","series-title":"WHO Classification of tumors of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.leukres.2013.01.009_bib0155","first-page":"811","article-title":"The International PTCL Project, International Peripheral T-Cell Lymphoma (PTCL) Clinical and Pathologic Review Project: Poor Outcome by Prognostic Indices and Lack of Efficacy with Anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood (ASH Annual Meeting)"},{"key":"10.1016\/j.leukres.2013.01.009_bib0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdq359","article-title":"Comparison of four prognostic scores in peripheral T-cell lymphoma","volume":"22","author":"Guti\u00e9rrez-Garc\u00eda","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2013.01.009_bib0165","first-page":"1","article-title":"Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia\/lymphoma","volume":"26","author":"Tokioka","year":"1994","journal-title":"Haematologia (Budap)"},{"key":"10.1016\/j.leukres.2013.01.009_bib0170","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.leukres.2006.11.013","article-title":"Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia\/lymphoma (ATLL)","volume":"31","author":"Takasaki","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.01.009_bib0175","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2009-05-220111","article-title":"Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.009_bib0180","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/annonc\/mdp531","article-title":"Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story","volume":"21","author":"Bari","year":"2010","journal-title":"Ann Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T18:50:34Z","timestamp":1714935034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0145212613000234"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.01.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}